GlaxoSmithKline (GSK) will refund covered entities that purchased certain formulations of a severe asthma treatment medication in the third quarter [...] …
Articles by : Shannon Young, Associate Editor/Senior Writer
340B covered entities could soon be required to share new information—including reimbursement amounts, ship to dates and ship to locations—as [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...] …
A former Pfizer executive and current biopharmaceutical consultant took aim this week at what she called the “poorly managed” 340B [...] …
AbbVie will no longer offer voluntary 340B pricing on any of its orphan-designated drugs to rural referral centers (RRC), sole [...] …
Although Massachusetts lawmakers left Beacon Hill this month without passing a long-stalled 340B contract pharmacy access bill, provider groups say [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...] …
More than two-thirds of 340B contract pharmacies are associated with pharmacy benefit managers (PBMs) through either vertical integration or contractual [...] …
The Senate panel responsible for federal appropriations legislation overwhelmingly passed a bill last week that would increase funding for the [...] …
Missouri’s new 340B contract pharmacy access law is getting increased attention in state primary races just days before voters head [...] …